Filing Details
- Accession Number:
- 0001181431-13-006520
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-02-04 19:12:29
- Reporting Period:
- 2013-01-31
- Filing Date:
- 2013-02-04
- Accepted Time:
- 2013-02-04 19:12:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1293310 | Kalobios Pharmaceuticals Inc | KBIO | Pharmaceutical Preparations (2834) | 770557236 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1555775 | Brigitte Smith | C/O Kalobios Pharmaceuticals, Inc. 260 East Grand Avenue South San Francisco CA 94080 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-01-31 | 25,000 | $8.00 | 25,000 | No | 4 | P | Indirect | By GBS Bioventures II A/C |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By GBS Bioventures II A/C |
Footnotes
- Represents securities held directly by GBS Bioventures II A/C ("Bioventures"). The Reporting Person is a managing director of GBS Venture Partners Pty Ltd which manages Bioventures. The Reporting Person shares voting and investment power with another partner and may be deemed to be an indirect beneficial owner of the reported securities. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of her pecuniary interest. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
Billionaire Hedge Funds
